peripheral t cell lymphoma

Showing NaN - NaN of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (brentuximab vedotin)

Terminated
  • Hodgkin Lymphoma
  • +2 more
  • brentuximab vedotin
  • Anaheim, California
  • +18 more
Dec 6, 2022

Peripheral T Cell Lymphoma Trial in Houston (Tenalisib)

Withdrawn
  • Peripheral T Cell Lymphoma
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 13, 2022

Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
Jul 21, 2022

Peripheral T Cell Lymphoma Trial in Korea, Republic of, United States (lacutamab)

Recruiting
  • Peripheral T Cell Lymphoma
  • lacutamab
  • Birmingham, Alabama
  • +18 more
Apr 4, 2022